AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Astrazeneca PLC.
Astrazeneca PLC business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Astrazeneca PLC are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Astrazeneca PLC , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Astrazeneca PLC including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Astrazeneca PLC and all latest updates of the company are provided.
The 2025 version of Astrazeneca PLC report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Astrazeneca PLC- Key Facts
2.2 Astrazeneca PLC- Geographic Locations
2.3 Astrazeneca PLC- Subsidiaries and Affiliates
2.4 Astrazeneca PLC- Business Divisions
2.5 Astrazeneca PLC- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Astrazeneca PLC Strategic Analysis Review
3.1 Astrazeneca PLC- Key Strategies
3.2 Astrazeneca PLC- Company Outlook Statement
3.3 Astrazeneca PLC- SWOT Analysis
3.3.1 Astrazeneca PLC- Key Strengths
3.3.2 Astrazeneca PLC- Key Weaknesses
3.3.3 Astrazeneca PLC- Potential Opportunities
3.3.4 Astrazeneca PLC- Potential Threats
3.4 Astrazeneca PLC- Key Competitors
4. Business Description of the Company
4.1 Astrazeneca PLC- Business Overview
4.2 Astrazeneca PLC- Operations by Segment
5 Products and Services Details
5.1 Astrazeneca PLC- Key Products
5.2 Astrazeneca PLC- Key Service Areas
5.3 Astrazeneca PLC- Key Brands
6 Company Developments
6.1 Astrazeneca PLC- Company History
6.2 Astrazeneca PLC- Latest Developments
7 Financial Analysis
7.1 Astrazeneca PLC- Income Statements
7.2 Astrazeneca PLC- Balance Sheet
7.3 Astrazeneca PLC- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Astrazeneca PLC- Direct Competitors
8.2 Astrazeneca PLC- Competitor Financial Ratios comparison
8.3 Astrazeneca PLC- Competitor Stock Charts Comparison
8.4 Astrazeneca PLC- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!